These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 1907770

  • 1. Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism.
    Ljunghall S, Larsson K, Lindh E, Lindqvist U, Rastad J, Akerström G, Wide L.
    Surgery; 1991 Jul; 110(1):47-53. PubMed ID: 1907770
    [Abstract] [Full Text] [Related]

  • 2. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP, Patron P, Fouqueray B, Prigent A, Paillard M.
    Miner Electrolyte Metab; 1988 Jul; 14(4):221-8. PubMed ID: 2850460
    [Abstract] [Full Text] [Related]

  • 3. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
    Bhadada SK, Cardenas M, Bhansali A, Mittal BR, Behera A, Chanukya GV, Nahar U, Rao DS.
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
    [Abstract] [Full Text] [Related]

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 5. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
    Brossard JH, Roy L, Lepage R, Gascon-Barré M, D'Amour P.
    Miner Electrolyte Metab; 1997 Nov; 23(1):25-32. PubMed ID: 9058366
    [Abstract] [Full Text] [Related]

  • 6. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism.
    Nussbaum SR, Potts JT.
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S43-50; discussion S61. PubMed ID: 1722383
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vivo studies of parathyroid gland function in secondary hyperparathyroidism.
    Salusky IB, Goodman WG.
    Adv Nephrol Necker Hosp; 1996 Oct; 25():289-302. PubMed ID: 8717632
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Progressive escape from parathyroid suppression: a common phenomenon in primary hyperparathyroidism (a calcium clamp study).
    Sørensen HA, Schwarz P, Hyldstrup L, Transbøl I.
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):309-15. PubMed ID: 8187293
    [Abstract] [Full Text] [Related]

  • 17. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago.
    Lundgren E, Hagström EG, Lundin J, Winnerbäck K, Roos J, Ljunghall S, Rastad J.
    World J Surg; 2002 Aug; 26(8):931-6. PubMed ID: 12045863
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.